A US court has upheld Shire's patent on its Lialda (mesalamine) ulcerative colitis delayed release tablets, in a legal tussle with Allergan subsidiaries Watson Pharma and Watson Laboratories.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback